Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Non-Current Debt (2020 - 2024)

Bio Essence has reported Non-Current Debt over the past 5 years, most recently at $1.4 million for Q1 2024.

  • For Q1 2024, Non-Current Debt rose 6064.53% year-over-year to $1.4 million; the TTM value through Mar 2024 reached $1.4 million, up 6064.53%, while the annual FY2023 figure was $608631.0, 2281.09% up from the prior year.
  • Non-Current Debt for Q1 2024 was $1.4 million at Bio Essence, up from $608631.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $1.4 million in Q1 2024 and troughed at $14549.0 in Q2 2021.
  • A 5-year average of $191109.6 and a median of $33443.0 in 2022 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: plummeted 83.48% in 2022 and later soared 6064.53% in 2024.
  • Year by year, Non-Current Debt stood at $212750.0 in 2020, then plummeted by 82.18% to $37918.0 in 2021, then plummeted by 32.59% to $25561.0 in 2022, then surged by 2281.09% to $608631.0 in 2023, then skyrocketed by 125.22% to $1.4 million in 2024.
  • Business Quant data shows Non-Current Debt for BIOE at $1.4 million in Q1 2024, $608631.0 in Q4 2023, and $17288.0 in Q3 2023.